OCELLOS

Live / Applied — First extension granted (statement of use) (as of 04 Sept 2025)

What this means for you

Not registered yet, but its 08 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98304980
Mark type
Stylized text
Filed
08 Dec 2023
Published for opposition
07 Jan 2025
Attorney of record
Bradley M. Stohry

Goods and services

  • Class 009 — Scientific and electric apparatus: Downloadable software for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Downloadable software for use in managing data for clinical trials; Downloadable software for chain of identity and chain of custody management in clinical trials and commercialization of medical therapies; Downloadable software for use in drug therapy development; Downloadable software for data analysis and reporting in the field of clinical trials and commercialization of medical therapies using artificial intelligence; Downloadable software for the provision of healthcare in the nature of providing medical diagnosis using artificial intelligence; Downloadable software for use in cell and gene therapy orchestration; Downloadable software for use in inventory management for scheduling and planning pharmaceutical resources; Downloadable software for use in control and tracking of cell and gene therapy products
  • Class 041 — Education and entertainment services: Arranging and conducting of training courses in the field of cell and gene therapy; Arranging and conducting of training workshops in the field of operation and development of software systems; Arranging and conducting of training workshops in the field of cell and gene therapy; Training services in the field of cell and gene therapy
  • Class 042 — Scientific and technological services: Platform as a service (PAAS) featuring computer software platforms for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Platform as a service (PAAS) featuring computer software platforms for use in managing data for clinical trials; Platform as a service (PAAS) featuring computer software platforms for chain of identity and chain of custody management in clinical trials and commercialization of medical therapies; Platform as a service (PAAS) featuring computer software platforms for use in drug therapy development; Platform as a service (PAAS) featuring computer software platforms for data analysis and reporting in the field of clinical trials and commercialization of medical therapies using artificial intelligence; Platform as a service (PAAS) featuring computer software platforms for use in the provision of healthcare in the nature of providing medical diagnosis using artificial intelligence; Platform as a service (PAAS) featuring computer software platforms for use in cell and gene therapy orchestration; Platform as a service (PAAS) featuring computer software platforms for use in inventory management for scheduling and planning pharmaceutical resources; Platform as a service (PAAS) featuring computer software platforms for use in control and tracking of cell and gene therapy products; Software as a service (SAAS) services featuring software platforms for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Software as a service (SAAS) services featuring software for use in managing data for clinical trials; Software as a service (SAAS) services featuring software for chain of identity and chain of custody management in clinical trials and commercialization of medical therapies; Software as a service (SAAS) services featuring software for use in drug therapy development; Software as a service (SAAS) services featuring software for data analysis and reporting in the field of clinical trials and commercialization of medical therapies using artificial intelligence; Software as a service (SAAS) services featuring software for use in the provision of healthcare in the nature of providing medical diagnosis using artificial intelligence; Software as a service (SAAS) services featuring software for use in cell and gene therapy orchestration; Software as a service (SAAS) services featuring software for use in pharmacy inventory management for scheduling and planning pharmaceutical resources; Software as a service (SAAS) services featuring software for use in control and tracking of cell and gene therapy products; Providing temporary use of non-downloadable cloud-based software for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Providing temporary use of non-downloadable cloud-based software for use in managing data for clinical trials; Providing temporary use of non-downloadable cloud-based software for chain of identity and chain of custody management in clinical trials and commercialization of medical therapies; Providing temporary use of non-downloadable cloud-based software for use in drug therapy development; Providing temporary use of non-downloadable cloud-based software for data analysis and reporting in the field of clinical trials and commercialization of medical therapies using artificial intelligence; Providing temporary use of non-downloadable cloud-based software for use in the provision of healthcare in the nature of providing medical diagnosis using artificial intelligence; Providing temporary use of non-downloadable cloud-based software for use in cell and gene therapy orchestration; Providing temporary use of non-downloadable cloud-based software for use in pharmacy inventory management for scheduling and planning pharmaceutical resources; Providing temporary use of non-downloadable cloud-based software for use in control and tracking of cell and gene therapy products
  • Class 045 — Legal and security services: Licensing of intellectual property in the field of cell and gene therapy; Software licensing; Granting of software licences

Owner

Prosecution history

  • 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 04 Sept 2025 — SOU EXTENSION 1 GRANTED
  • 04 Sept 2025 — SOU EXTENSION 1 FILED
  • 04 Sept 2025 — SOU TEAS EXTENSION RECEIVED
  • 04 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 07 Jan 2025 — PUBLISHED FOR OPPOSITION
  • 01 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 10 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 10 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 10 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 10 Oct 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 17 Jul 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 17 Jul 2024 — NON-FINAL ACTION E-MAILED
  • 17 Jul 2024 — NON-FINAL ACTION WRITTEN

View this trademark record on Marksy